Generic Product News (April 2018)
Read about the generic products featured in April.
Camber Pharmaceuticals
COMPARE TO: Celexa (Forest Laboratories, Inc)
INDICATION: Camber has launched its generic version of Celexa (citalopram) Oral Solution, indicated for the treatment of depression. Citalopram oral solution is available in a 10-mg/5-mL 240-mL bottle.
DOSAGE FORM: Oral solution
FOR MORE INFORMATION: camberpharma.com
ISOTRETINOIN CAPSULES, USPMARKETED BY: Amneal Pharmaceuticals
COMPARE TO: Accutane (Roche)
INDICATION: Amneal Pharmaceuticals has launched Isotretinoin capsules, USP, an AB-rated generic for Accutane in 10-, 20-, 30, and 40-mg strengths. Isotretinoin capsules are indicated for the treatment of severe recalcitrant nodular acne.
DOSAGE FORM: Capsules
FOR MORE INFORMATION: amneal.com
BUMETANIDE TABLETS, USPMARKETED BY: Upsher-Smith
COMPARE TO: Bumex (Hoffmann-La Roche, Inc)
INDICATION: The FDA has approved Upsher-Smith Laboratories’ abbreviated new drug application for Bumetanide tablets, the generic version of Bumex. Bumenatide tablets are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome.
DOSAGE FORM: Tablets
FOR MORE INFORMATION: upsher-smith.com
MEMANTINE HYDROCHLORIDEMARKETED BY: Amneal Pharmaceuticals
COMPARE TO: Namenda XR (Allergan)
INDICATION: Amneal Pharmaceuticals has launched Memantine Hydrochloride extended-release capsules, the company’s AB-rated equivalent for Namenda XR in 7-, 14-, 21-, and 28- strengths. Namenda XR is indicated for the treatment of moderate to severe dementia of the Alzheimer type.
DOSAGE FORM: Extended-release capsules
FOR MORE INFORMATION: amneal.com
Articles in this issue
over 7 years ago
Article
Managing Allergic Rhinitis: Tips to Improve Therapeutic Selection and Symptom ControlNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
Advise Patients About Self-Care Measures to Treat Mild to Moderate GI IssuesSeptember 18th 2025
Evaluation of Pharmacist-Driven Penicillin Allergy ReconciliationSeptember 17th 2025
Pharmacists Can Apply Their Expertise to the Medical Psilocybin ActSeptember 16th 2025
From Curiosity to Clinical Impact: Shremo Msdi’s Path in Pharmacy ResearchSeptember 15th 2025
